Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35816318.
- Also identified by DOI 10.1001/jamanetworkopen.2022.21468 and PMC identifier 9280395.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study examines trends in drug spending in Medicare Parts B and D and describes the share of total use and spending attributed to oncology drugs within each program.
Medical subject headings
- Health Expenditures
- Medicare